All News #Library
Biotech
Vaximm Names Sébastien Wieckowski, Phd, Chief Scientific Officer
16 Jan 2026 //
PR NEWSWIRE
Vaximm AG Announces Phase 2a Trial Results for Glioblastoma
26 Mar 2025 //
PR NEWSWIRE

Market Place
Sourcing Support